Times are changing within the realm of published medical studies. More and more, experts are questioning assertions made decades ago, choosing instead to examine data in a new light. As a result, retractions are at an all-time high, published works are proving to be inaccurate, the allegations of fraud are... Read more »

According to a recent announcement by Actos manufacturer Takeda Pharmaceuticals, over 96 percent of the eligible claimants have agreed to take part in the Actos product liability resolution program. Through the program, over 9,000 plaintiffs may receive compensation for their injuries without the uncertainty that exists in continued litigation. With over... Read more »

The U.S. Food and Drug Administration (FDA) has released a new drug safety communication regarding Invokana and Invokamet (canagliflozin). The safety announcement, which was released on September 10, 2015, adds a new warning to the drug’s label and updates the adverse reactions section with regard to the risk of bone... Read more »

On August 7, 2015, five plaintiffs from as many states filed a joint complaint adding a Xarelto internal bleeding lawsuit to ongoing multi-district litigation (“MDL”). There are more than 500 Xarelto lawsuits already included in the MDL. The complex litigation is being overseen by U.S. District Judge Eldon Fallon in... Read more »

In July, researchers from the University of North Carolina at Chapel Hill published a study on testosterone heart risks in the medical journal, JAMA Internal Medicine, finding that the side effects of testosterone injections may pose the highest risk of cardiovascular events, hospitalizations and deaths. The team examined the comparative... Read more »

Earlier this year, the U.S. Food and Drug Administration (FDA) published a safety communication that alerts consumers about an increased risk of diabetic ketoacidosis (DKA) with the use of sodium–glucose cotransporter 2 (SGLT2) inhibitors, including Invokana, Invokamet, Farxiga, Jardiance and others. Diabetic ketoacidosis is a potentially life-threatening complication of diabetes... Read more »

Adding to a growing body of research linking Risperdal and gynecomastia in young boys and men, a recent study published in the Journal of Child and Adolescent Psychopharmacology has revealed a correlation between the two following an intense look at over 15,000 cases. The study, which was published online ahead... Read more »

The latest Actos trial to begin in U.S. courts started on Thursday, August 27 in Las Vegas, under the direction of Judge Jerry Wiese II. Attorneys working for two southern Nevada claimants argue that their clients suffered severe side effects from the diabetes drug, including death. The trial is expected to... Read more »

Drug maker GlaxoSmithKline (GSK) is named defendant in a Zofran lawsuit alleging the drug carries a disproportionate risk of causing congenital birth defects when taken by pregnant women. The complaint was filed by a minor plaintiff and her parents in the United States District Court for the Northern District of... Read more »

In the August 20, 2015 issue of the New England Journal of Medicine, FDA researchers published an article that expressed their concerns regarding testosterone therapy side effects. Specifically, they are concerned about the use of these products by men who have declining testosterone caused by the natural aging process, rather... Read more »